Wen, P., Stein, A., van den Bent, M., De Greve, J., Dietrich, S., De Vos, F., von Bubnoff, N., van Linde, M., Lai, A., Prager, G., Campone, M., Fasolo, A., Lopez-Martin, J., Min Kim, T., Mason, W., Hofheinz, R., Blay, J., Cho, D., Gazzah, A., Gomez-Roca, C., Yachnin, J., Boran, A., Burgess, P., Palanichamy, I., Gasal, E., & Subbiah, V. (n.d.). aCTR-30. UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG). Neuro-oncology, 21, vi19–vi20. http://access.bl.uk/ark:/81055/vdc_100101669180.0x00003a